Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease
1. About lecanemab (generic name, brand name: Leqembi®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal ...
Exclusive: Reeves to reveal new mutual council with Nationwide and Co-Op
Chancellor Rachel Reeves will set out plans for a new mutual council today made up of some of Britain’s biggest customer and member-owned firms, including Nationwide, Royal London and the Co-Op Group, ...